News & Alerts
-
Dec- 2023 -21 December
India Implements Ban on Anti-Cold Drug for Children: A Response to Global Cough Syrup Contamination Crisis
India has taken a significant step to address the alarming issue of child deaths linked to contaminated cough syrups by…
Read More » -
20 December
Autism Spectrum Disorder Therapeutics Market to Grow at a Substantial Growth Rate During the Study Period (2019-2032)
DelveInsight’s Autism Spectrum Disorder Market Insights report highlights the expected substantial growth of the Autism Spectrum Disorder Therapeutics Market from…
Read More » -
20 December
Contract Manufacturing Outsourcing of Sterile Injectable Drugs Market to Surpass US$24.2 Billion by 2024
In a recent market report, it has been predicted that the Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market…
Read More » -
20 December
Biogen Faces Setback as Europe Revokes Marketing Authorization for Tecfidera Generics
In a significant development, Biogen Inc. announced on Tuesday that the European Commission has revoked the marketing authorization for generic…
Read More » -
20 December
Judge Dismisses Tylenol-Autism Link Lawsuits, Citing Lack of Scientific Support
In a significant legal development, a judge has ruled against expert witnesses who claimed that Tylenol, a painkiller produced by…
Read More » -
20 December
G-Dragon Triumphs: K-Pop Icon Cleared of Drug Allegations in Stunning Police Decision
In a recent turn of events, South Korean police have officially cleared K-Pop sensation G-Dragon, also known as Kwon Ji-yong,…
Read More » -
20 December
AvertD Test: FDA Unveils Breakthrough in Predicting Opioid Addiction, Sparking Pain Management Revolution
In a groundbreaking move, the U.S. Food and Drug Administration (FDA) announced on Tuesday its approval of the first-ever test…
Read More » -
19 December
GSK’s Cancer Drug Combination Achieves Primary Goal in Late-Stage Trial for Endometrial Cancer
GlaxoSmithKline (GSK) announced on Monday that the combination of its cancer drugs Zejula and Jemperli, utilized as a maintenance therapy…
Read More » -
19 December
Weight-Loss Drug Excitement Overshadows Market Realities in 2023
In 2023, the enthusiasm surrounding weight-loss drugs, particularly Novo Nordisk’s Wegovy (also known as Ozempic) and Eli Lilly’s Zepbound, has…
Read More » -
19 December
IndiaMART Removes Unauthorized Listings of Novo Nordisk’s Wegovy Following Talks
IndiaMART, a prominent Indian online marketplace, has taken steps to remove unauthorized listings of Novo Nordisk’s blockbuster weight-loss drug Wegovy,…
Read More »